Company News

Skinvisible Signs Dermatology Agreement With RHEI

New partnership introduces Invisicare to China

Author Image

By: TOM BRANNA

Editor

Skinvisible, Inc., the developers of Invisicare, a patented polymer delivery system that provides life cycle management for topical products, and RHEI Pharmaceuticals NV, a Belgium-based pharmaceutical company that in-licenses drugs for sale in China, announced they have signed a first option agreement. The agreement gives RHEI the first option to license the exclusive rights for Skinvisible’s dermatology products for the territory of China, Hong Kong and Taiwan. Specifically the agree...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters